Igor Aurrekoetxea
Leioa, PV 48940, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
E2F2 transcription factor promotes a cholestatic MASH phenotype by regulating hepatobiliary metabolism through miR-34a-5p.
Journal: Hepatology (Baltimore, Md.)
Published: January 30, 2025
Neddylation inhibition prevents acetaminophen-induced liver damage by enhancing the anabolic cardiolipin pathway.
Journal: Cell reports. Medicine
Published: September 27, 2023
In Vivo Tissue Lipid Uptake in Antisense Oligonucleotide (ASO)-Treated Mice.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 31, 2023
In Vivo Hepatic Triglyceride Secretion Rate in Antisense Oligonucleotide (ASO)-Treated Mice.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 31, 2023
Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids.
Journal: Hepatology (Baltimore, Md.)
Published: May 03, 2021
Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis.
Journal: Nature communications
Published: July 24, 2020
E2F1 and E2F2-Mediated Repression of CPT2 Establishes a Lipid-Rich Tumor-Promoting Environment.
Journal: Cancer research
Published: June 16, 2020
Role of Aramchol in steatohepatitis and fibrosis in mice.
Journal: Hepatology communications
Published: November 22, 2017
Deregulated neddylation in liver fibrosis.
Journal: Hepatology (Baltimore, Md.)
Published: December 15, 2015
Last Updated: 09/26/2026